X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (41) 41
transplantation (40) 40
index medicus (31) 31
humans (30) 30
hematology, oncology and palliative medicine (25) 25
middle aged (25) 25
adult (24) 24
female (24) 24
male (23) 23
aged (21) 21
hematopoietic stem cells (17) 17
adolescent (15) 15
oncology (14) 14
survival (13) 13
hematopoietic stem cell transplantation (12) 12
immunology (12) 12
article (11) 11
mortality (11) 11
analysis (10) 10
retrospective studies (9) 9
stem cells (9) 9
treatment outcome (9) 9
young adult (9) 9
abridged index medicus (8) 8
child, preschool (8) 8
clinical medicine (8) 8
transplantation, homologous (8) 8
cancer (7) 7
child (7) 7
hematopoietic-cell transplantation (7) 7
acute myeloid-leukemia (6) 6
allogeneic transplantation (6) 6
blood (6) 6
bone marrow (6) 6
disease-free survival (6) 6
infant (6) 6
klinisk medicin (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
prognosis (6) 6
risk factors (6) 6
survival analysis (6) 6
survival rate (6) 6
transplantation conditioning (6) 6
acute myelogenous leukemia (5) 5
graft vs host disease - mortality (5) 5
graft vs host disease - prevention & control (5) 5
health aspects (5) 5
hematologi (5) 5
hematopoietic stem cell transplantation - adverse effects (5) 5
hemic and lymphatic diseases (5) 5
impact (5) 5
lymphomas (5) 5
marrow-transplantation (5) 5
medical research (5) 5
medicine, experimental (5) 5
prospective studies (5) 5
risk (5) 5
acute disease (4) 4
acute myeloid leukemia (4) 4
allografts (4) 4
bone-marrow (4) 4
bone-marrow-transplantation (4) 4
cytogenetics (4) 4
immune system diseases (4) 4
multiple myeloma (4) 4
multivariate analysis (4) 4
outcomes (4) 4
prophylaxis (4) 4
stem-cell transplantation (4) 4
surgical procedures, operative (4) 4
therapy (4) 4
time factors (4) 4
transplantation conditioning - methods (4) 4
unrelated donors (4) 4
working party (4) 4
acute gvhd (3) 3
aged, 80 and over (3) 3
antineoplastic agents - adverse effects (3) 3
autografts (3) 3
busulfan (3) 3
busulfan - administration & dosage (3) 3
care and treatment (3) 3
chemotherapy (3) 3
clinical trials (3) 3
drug resistance (3) 3
etanercept (3) 3
features (3) 3
graft vs host disease - blood (3) 3
graft vs host disease - drug therapy (3) 3
gvhd (3) 3
hematopoietic stem cell transplantation - methods (3) 3
hematopoietic stem cell transplantation - mortality (3) 3
hemopoiesis (3) 3
incidence (3) 3
leukemia, myeloid, acute - therapy (3) 3
multiple myeloma - therapy (3) 3
patients (3) 3
recurrence (3) 3
reduced-intensity (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. 87 - 95
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2018, Volume 182, Issue 6, pp. 916 - 920
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3141 - 3149
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3276 - 3276
Background Graft versus host disease (GVHD) is the principal cause of non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo HCT)... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S12 - S13
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 01/2019, Volume 12, Issue 1, pp. 6 - 11
Journal Article
Blood, ISSN 0006-4971, 08/2017, Volume 130, Issue 9, pp. 1156 - 1164
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S26 - S27
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S68 - S69
The composite endpoint of GVHD-free, relapse-free survival (GRFS), defined as survival free from grade 3--4 acute GVHD (aGVHD), chronic GVHD (cGVHD) requiring... 
Medical research | Monte Carlo method | Immunotherapy | Stem cells | Clinical trials | Medicine, Experimental | Lymphomas
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5875 - 5875
Abstract Chronic graft-versus-host disease (cGVHD) is the most important long-term complication of allogeneic hematopoietic cell transplantation (HCT). As... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2016, Volume 174, Issue 2, pp. 235 - 248
Summary For diffuse large B‐cell lymphoma (DLBCL) patients progressing after autologous haematopoietic cell transplantation (autoHCT), allogeneic HCT (alloHCT)... 
prognostic score |